2,179
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Future potential of Rapid Acceleration of Diagnostics (RADx Tech) in molecular diagnostics

, , , , &
Pages 251-253 | Received 20 Jan 2021, Accepted 01 Mar 2021, Published online: 09 Mar 2021

References

  • Tromberg BJ, Schwetz TA, Pérez-Stable EJ, et al., Rapid scaling up of Covid-19 diagnostic testing in the United States - the NIH RADx Initiative. N Engl J Med. 2020;383(11):1071–1077.
  • Van Norman GA. Drugs, devices, and the FDA: part 2: an overview of approval processes: FDA approval of medical devices. JACC Basic Transl Sci. 2016;1(4):277–287.
  • Ford Carleton P, Schachter S, Parrish JA, et al. National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network: advancing precision medicine. IEEE J Transl Eng Health Med. 2016 Aug;16(4):2800614.
  • Carleton PF, Schachter S, Lash TB, et al. Point-of-Care Technology Research Network: an evolving model for collaborative translational research in biomedical engineering. Curr Opin Biomed Eng. 2019;11:145–148.
  • Korte BJ, Rompalo A, Manabe YC, et al. Overcoming challenges with the adoption of point-of-care testing: from technology push and clinical needs to value propositions. Point Care. 2020;19(3):77–83.
  • Informa. Molecular diagnostics: US, five major European markets, Japan, and rest of world. Meddevicetracker. 2020;MDT20012:1–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.